High-dose therapy and autologous stem cell transplantation (ASCT) for systemic AL amyloidosis (AL): A report on 16 cases.

被引：0
|
作者：
Moreau, P [1 ]
Facon, T [1 ]
Leblond, V [1 ]
Attal, M [1 ]
Caillot, D [1 ]
Nedellec, G [1 ]
Huynh, A [1 ]
Bataille, R [1 ]
Harousseau, JL [1 ]
机构：
[1] DEPT HEMATOL,NANTES,FRANCE
来源：
EXPERIMENTAL HEMATOLOGY | 1997年 / 25卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [31] An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis
    Sanchorawala, Vaishali
    Seldin, David C.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2007, 14 (04): : 261 - 269
  • [32] High-dose melphalan and autologous bone marrow transplantation for systemic AL amyloidosis with cardiac involvement
    Moreau, P
    Milpied, N
    deFaucal, P
    Petit, T
    Herbouiller, P
    Bataille, R
    Harousseau, JL
    BLOOD, 1996, 87 (07) : 3063 - 3064
  • [33] High-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis: NYHA stage and number of involved organs are predictable for proceeding to high-dose therapy
    Schonland, S
    Hegenbart, U
    Dengler, J
    Benner, A
    Hundemer, M
    Bochtler, T
    Ho, A
    Goldschmidt, H
    BONE MARROW TRANSPLANTATION, 2006, 37 : S6 - S6
  • [34] Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis
    Gillmore, JD
    Goodman, HJ
    Lachmann, HJ
    Offer, M
    Wechalekar, AD
    Joshi, J
    Pepys, MB
    Hawkins, PN
    BLOOD, 2006, 107 (03) : 1227 - 1229
  • [35] High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators
    Pooja Phull
    Vaishali Sanchorawala
    Dina Brauneis
    J. Mark Sloan
    Omar K. Siddiqi
    Karen Quillen
    Shayna Sarosiek
    Bone Marrow Transplantation, 2019, 54 : 1304 - 1309
  • [36] Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis
    Nguyen, V. P.
    Brauneis, D.
    Kaku, M.
    Sloan, J. M.
    Sarosiek, S.
    Quillen, K.
    Shelton, A. C.
    Sanchorawala, V.
    BONE MARROW TRANSPLANTATION, 2018, 53 (03) : 371 - 373
  • [37] Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis
    S Y Lee
    R S Meehan
    D C Seldin
    J M Sloan
    K Quillen
    A Shelton
    D Brauneis
    V Sanchorawala
    Bone Marrow Transplantation, 2016, 51 : 1318 - 1322
  • [38] Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation
    Seldin, DC
    Anderson, JJ
    Sanchorawala, V
    Malek, K
    Wright, DG
    Quillen, K
    Finn, KT
    Berk, JL
    Dember, LM
    Falk, RH
    Skinner, M
    BLOOD, 2004, 104 (06) : 1888 - 1893
  • [39] Brachial Plexopathy Following High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation for AL Amyloidosis
    Vina Nguyen
    Brauneis, Dina
    Sloan, John Mark
    Sarosiek, Shayna
    Quillen, Karen
    Shelton, Anthony C.
    Sanchorawala, Vaishali
    BLOOD, 2017, 130
  • [40] Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis
    V. P. Nguyen
    D. Brauneis
    M. Kaku
    J. M. Sloan
    S. Sarosiek
    K. Quillen
    A. C. Shelton
    V. Sanchorawala
    Bone Marrow Transplantation, 2018, 53 : 371 - 373
12345